Stay updated on Olaparib in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib in BRCA Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedA new bibliographic citation was added documenting the adverse-event profile in BRCA-mutated, platinum-sensitive relapsed ovarian cancer (SOLO2 trial) from Int J Gynecol Cancer, 2026. The page revision tag was updated from v3.6.0 to v3.6.2.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe Study Details page now includes user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice stating 'No longer looking for participants.' The Intervention/Treatment heading has been standardized (replacing 'Intervention / Treatment'), and the page footer revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check24 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, marking a new version of the page for tracking updates. This change is a non-substantive metadata update and does not modify the study details or results.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page revision tag has been updated to Revision: v3.5.4, replacing the previous v3.5.3, indicating a small update to the page's revision history.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page’s footer revision/version indicator was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Olaparib in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.